Improving Medicines for Children in Canada

Improving Medicines for Children in Canada PDF

Author: The Expert Panel on Therapeutic Products for Infants, Children, and Youth

Publisher: Council of CanadianAcademies

Published: 2014-09

Total Pages: 292

ISBN-13: 1926558855

DOWNLOAD EBOOK →

"Recognizing the importance of developing safe and effective medicines specifically for children, the Minister of Health, on behalf of Health Canada, asked the Council of Canadian Academies to provide an evidence-based and authoritative assessment of the state of research and regulations leading to the approval of therapeutic products for children, in Canada and abroad. Specifically, this assessment examines the following questions: What is the state of clinical pharmacology, in Canada and abroad, that can be applied to the ethical development of safe and effective pharmaceuticals and biologics labelled as therapies for infants, children, and youth? How does human development from infancy to youth alter clinical pharmacology and therefore inform pediatric drug investigations? What are best practices to ethically conduct scientifically sound but adaptive drug studies to confirm the safety and effectiveness of drugs for infants, children, and youth? When the participation of infants, children, and youth in drug studies is not feasible, what are the best practices to confirm drug safety and effectiveness in these populations? What are Canada's strengths to contribute to global pharmacovigilance efforts for drugs that may benefit infants, children, and youth?"--Executive summary.

Improving Medicines for Children in Canada

Improving Medicines for Children in Canada PDF

Author: Council of Canadian Academies. Expert Panel on Therapeutic Products for Infants, Children, and Youth

Publisher:

Published: 2014

Total Pages:

ISBN-13: 9781926558868

DOWNLOAD EBOOK →

"Recognizing the importance of developing safe and effective medicines specifically for children, the Minister of Health, on behalf of Health Canada, asked the Council of Canadian Academies to provide an evidence-based and authoritative assessment of the state of research and regulations leading to the approval of therapeutic products for children, in Canada and abroad. Specifically, this assessment examines the following questions: What is the state of clinical pharmacology, in Canada and abroad, that can be applied to the ethical development of safe and effective pharmaceuticals and biologics labelled as therapies for infants, children, and youth? How does human development from infancy to youth alter clinical pharmacology and therefore inform pediatric drug investigations? What are best practices to ethically conduct scientifically sound but adaptive drug studies to confirm the safety and effectiveness of drugs for infants, children, and youth? When the participation of infants, children, and youth in drug studies is not feasible, what are the best practices to confirm drug safety and effectiveness in these populations? What are Canada's strengths to contribute to global pharmacovigilance efforts for drugs that may benefit infants, children, and youth?"--Executive summary.

Why We Need More Canadian Health Policy in the Media

Why We Need More Canadian Health Policy in the Media PDF

Author: Noralou Roos

Publisher: EvidenceNetwork.ca

Published: 2016-06-21

Total Pages: 351

ISBN-13: 0995157324

DOWNLOAD EBOOK →

Why We Need More Canadian Health Policy in the Media is a compilation of health policy commentaries published by EvidenceNetwork.ca experts in major newspapers in 2015. These articles highlight the most recent evidence on a wide range of health policy topics, including our aging population, healthcare costs and spending, mental health, pharmaceutical policy, the social determinants of health and distinctions between the Canadian and American healthcare system among other topics. This is the fourth volume in the annual series of eBooks produced by EvidenceNetwork.ca, the first being Canadian Health Policy in the News (2013), followed by Making Evidence Matter in Canadian Health Policy (2014) and Navigating the Evidence: Communicating Canadian Health Policy in the Media (2015). We acknowledge the Canadian Institutes for Health Research, Research Manitoba, the Manitoba Centre for Health Policy, the George and Fay Yee Centre for Healthcare Innovation, CIHR’s Institute of Health Services and Policy Research, and their Institute of Population and Public Health, The Canadian Frailty Network, and the University of Manitoba’s Department of Community Health Sciences and Max Rady College of Medicine whose funding supports EvidenceNetwork.ca.

Optimizing Treatment for Children in the Developing World

Optimizing Treatment for Children in the Developing World PDF

Author: Stuart MacLeod

Publisher: Springer

Published: 2015-05-12

Total Pages: 333

ISBN-13: 3319157507

DOWNLOAD EBOOK →

This book is intended to communicate current best practice in pediatric clinical pharmacology and clinical pharmacy with special consideration of the prevailing circumstances and most pressing needs in developing countries. It also addresses measures that may be taken in countries with emerging economies through organizational and political adjustments to reduce unacceptable levels of morbidity and mortality among children and pregnant women with treatable diseases.

Building on Canada's Strengths in Regenerative Medicine

Building on Canada's Strengths in Regenerative Medicine PDF

Author: Workshop Steering Committee

Publisher: Council of Canadian Academies

Published: 2017

Total Pages: 60

ISBN-13: 1926522230

DOWNLOAD EBOOK →

"Many disease treatments manage the symptoms of a condition, but fail to treat its underlying causes. The appeal of regenerative medicine lies in its curative approach. It replaces or regenerates human cells, tissues, or organs to restore or establish normal function using stem cells. A well-established example of regenerative medicine is the use of bone marrow transplants for leukemia. Regenerative medicine has the potential to transform healthcare by treating previously incurable chronic diseases and conditions, including diabetes, heart disease, osteoporosis, and spinal cord injuries. In doing so it could also improve the quality of peoples' lives and generate significant economic benefits. Regenerative medicine is a multidisciplinary field, involving a number of stakeholders throughout the development process; from the scientists who make applied research discoveries which enable the possibility of treatment, through regulatory hurdles and industry investment, to end-point clinicians offering these treatments to patients. The CCA's workshop will bring together experts from a variety of disciplines and sectors to offer insight into the state of regenerative medicine in Canada, and identify opportunities and challenges to ensure future Canadian excellence."--

Patient Assessment in Clinical Pharmacy

Patient Assessment in Clinical Pharmacy PDF

Author: Sherif Hanafy Mahmoud

Publisher: Springer

Published: 2019-03-28

Total Pages: 432

ISBN-13: 3030117758

DOWNLOAD EBOOK →

This comprehensive, first-of-its kind title is an indispensable resource for pharmacists looking to learn or improve crucial patient assessment skills relevant to all pharmacy practice settings. Pharmacists’ role as health care practitioners is evolving as they are taking a more active part in primary patient care -- helping patients manage their medications and diseases, providing patient education, and, in some jurisdictions, prescribing and adapting medications. To perform their day-to-day duties, pharmacists are best-served using a framework called the patient care process. This framework involves three steps: patient assessment; care plan development and implementation; and monitoring and follow up. Organized in four parts, this practical book begins with introductory chapters regarding the basics of patient assessment and the patient care process. Part II includes a detailed assessment of common symptoms encountered by pharmacists. Part III discusses assessment of patients with various chronic illnesses. Part IV addresses select specialized topics and assessment considerations. An invaluable contribution to the literature, Patient Assessment in Clinical Pharmacy: A Comprehensive Guide will be of great benefit to pharmacists, regardless of their practice setting, and to pharmacy students as well.

WHO Expert Committee on Specifications for Pharmaceutical Preparations

WHO Expert Committee on Specifications for Pharmaceutical Preparations PDF

Author: World Health Organization

Publisher: World Health Organization

Published: 2016

Total Pages: 374

ISBN-13: 9241209968

DOWNLOAD EBOOK →

The World Health Organization (WHO) Expert Committee on Specifications for Pharmaceutical Preparations advises the Director-General of WHO in the area of medicines quality assurance. It provides independent expert recommendations and guidance to ensure that medicines meet standards of quality, safety and efficacy in all WHO Member States. Its advice is developed through a broad consensus-building process and covers all areas of quality assurance of medicines, from their development to their distribution to patients. In the area of quality control, the Expert Committee reviewed new and revised specifications and general texts for inclusion in The International Pharmacopoeia, and received the annual report of the European Directorate for the Quality of Medicines & HealthCare (EDQM), the custodian centre for International Chemical Reference Substances (ICRS). The Committee adopted a number of monographs, general texts and ICRS. It noted the report on Phase 6 of the External Quality Assurance Assessment Scheme (EQAAS) and on new approaches to ensure sustainability of this scheme through user fees. The Committee further acknowledged the progress of good pharmacopoeial practices (GPhP), and adopted the document on GPhP which was prepared by the consecutive international meetings of world pharmacopoeias. In the various quality assurance-related areas the Expert Committee was presented with a number of new and revised guidelines related to good manufacturing practices (GMP), distribution and trade of pharmaceuticals and regulatory practice. It adopted 10 guidelines as listed below as well as 22 new specifications and general texts for inclusion in The International Pharmacopoeia. The Committee took note of ongoing work to promote collaboration and information exchange through the good regulatory practice project and welcomed the development of a comprehensive set of guidelines for all national regulatory authorities through this project.

Canadian Immunization Guide

Canadian Immunization Guide PDF

Author: Canada. Comité consultatif national de l'immunisation

Publisher:

Published: 2006

Total Pages: 392

ISBN-13: 9780660193922

DOWNLOAD EBOOK →

The seventh edition of the Canadian Immunization Guide was developed by the National Advisory Committee on Immunization (NACI), with the support ofthe Immunization and Respiratory Infections Division, Public Health Agency of Canada, to provide updated information and recommendations on the use of vaccines in Canada. The Public Health Agency of Canada conducted a survey in 2004, which confi rmed that the Canadian Immunization Guide is a very useful and reliable resource of information on immunization.

Pharmacoepidemiology

Pharmacoepidemiology PDF

Author: Brian L. Strom

Publisher: John Wiley & Sons

Published: 2019-12-16

Total Pages: 1220

ISBN-13: 1119413419

DOWNLOAD EBOOK →

This classic, field-defining textbook, now in its sixth edition, provides the most comprehensive guidance available for anyone needing up-to-date information in pharmacoepidemiology. This edition has been fully revised and updated throughout and continues to provide a rounded view on all perspectives from academia, industry and regulatory bodies, addressing data sources, applications and methodologies with great clarity.

Handbook of Autism and Pervasive Developmental Disorder

Handbook of Autism and Pervasive Developmental Disorder PDF

Author: Johnny L. Matson

Publisher: Springer Nature

Published: 2022-08-11

Total Pages: 1579

ISBN-13: 3030885380

DOWNLOAD EBOOK →

This handbook provides a substantive foundation of autism theory and research, including a comprehensive overview, conceptualization, and history of autism spectrum disorder (ASD) and pervasive developmental disorder (PDD). This robust reference work integrates the broad scholarly base of literature coupled with a trenchant analysis of the state of the field in nosology, etiology, assessment, and treatment. Its expert contributors examine findings and controversies (e.g., the actual prevalence of autism) as well as longstanding topics of interest as well as emerging issues from around the globe. In addition, the handbook describes multiple assessments, diagnoses, interventions and treatments for autism and PDD. It addresses such key topics as assessment of core symptoms and comorbidities, risk factors, epidemiology, diagnostic systems, neuroscience as well as issues regarding family adaptation. In addition, the handbook explores the rapidly evolving and expanding topics of medications, diets, fringe and harmful treatments, applied behavior analysis, and early intensive behavioral interventions. Key areas of coverage include: Survey of diagnostic criteria and assessment strategies for autism and pervasive developmental disorder. Genetic, behavioral, biopsychosocial, and cognitive models of autism assessment and treatment. Psychiatric disorders in individuals with ASD. Theory of mind and facial recognition in persons with autism. Diagnostic instruments for assessing core features and challenging behaviors in autism and PDD. Evidence-based psychosocial, pharmacological, and integrative treatments for autism and other developmental disabilities. Interventions specifically for adults with ASD. Training issues for professionals, parents, and other caregivers of individuals with autism and developmental disabilities. Review of findings of successful and promising therapies coupled with guidance on how to distinguish between dubious and effective treatments for autism and PDD. The handbook is an indispensable resource for researchers, professors, graduate students as well as clinicians, therapists, and other practitioners in clinical child and school psychology, child and adolescent psychiatry, social work, special education, behavioral rehabilitation, pediatric medicine, developmental psychology, and all allied disciplines.